level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 35 /hr
Hire Dr. Rajesh S.
India
USD 35 /hr

Scientific Editor & Reviewer | PhD in Medical Microbiology | 8+ Yrs Assistant Professor

Profile Summary
Subject Matter Expertise
Services
Writing Non-Medical Regulatory Writing, Technical Writing, Copywriting
Research User Research, Gap Analysis
Consulting Healthcare Consulting
Data & AI Statistical Analysis
Product Development Manufacturing
Work Experience

Assistant professor in Medical Microbiology

Haramaya University

October 2017 - July 2025

Education

Post Doctoral Fellow (Senior Microbiologist) (Dept. Integrated Bio-Medical Sciences)

University of Cape Town

August 2016 - December 2016

PhD in Medical Microbiology (Medical Microbiology )

University of Cape Town

September 2007 - June 2013

Certifications
Publications
JOURNAL ARTICLE
Abebe Dawud, Tadesse Shume, Rajesh Sarkar, Mandie Maru, Olifan Getachew Wakjira, Ajay Kumar Prajapati, Dadi Marami, Tewodros Tesfa (2025). Magnitude of vancomycin-resistant Enterococci colonization and associated factors among people living with HIV . JAC-Antimicrobial Resistance.
Priyanka Ganapathy, Vidya Devanatha Desikan Sheshadri, Rajesh Sarkar, Sumathi Jones, Krishnamoorthy Gunasekaran, Teka Obsa Feyisa, Dhamodharan Umapathy, Saleem Basha (2023). Vascular Endothelial Growth Factor Single Nucleotide Polymorphism +405 G/C (rs2010963) is associated with Levels, Infection Severity, and Amputation among South Indian Diabetic Foot Ulcer Patients . Evidence-Based Complementary and Alternative Medicine.
Senthilkumar Balakrishnan, Senbagam Duraisamy, Murugan Kasi, Selvam Kandasamy, Rajesh Sarkar, Anbarasu Kumarasamy (2019). Syntheses, physicochemical characterization, antibacterial studies on potassium morpholine dithiocarbamate nickel (II), copper (II) metal complexes and their ligands . Heliyon.
R. Sarkar, C. Mdladla, L. Macingwana, R.-D. Pietersen, A.H. Ngwane, D.L. Tabb, P.D. van Helden, I. Wiid, B. Baker (2018). Proteomic analysis reveals that sulfamethoxazole induces oxidative stress in M. tuberculosis . Tuberculosis.
Rajesh Sarkar, Laura Lenders, Katalin A. Wilkinson, Robert J. Wilkinson, Mark P. Nicol (2012). Modern Lineages of Mycobacterium tuberculosis Exhibit Lineage-Specific Patterns of Growth and Cytokine Induction in Human Monocyte-Derived Macrophages . PLoS ONE.
BOOK CHAPTER
AN OVERVIEW OF URINARY TRACT INFECTION Between 20 and 30 percent of women will encounter recurrent urinary tract infections at some point in their lives. The urinary tract is a common site of bacterial infection, particularly in women. Urinary tract infections are less common in men and typically happen beyond 50. Even though the majority of infections in men are acute and transient, they nevertheless greatly increase the population's morbidity. Serious long-term implications result from severe infections, including loss of kidney function. An exception is made for vaginitis, urethritis, and cystitis in females; nevertheless, the genitourinary system is a range, with signs often overlapping. Most often, a bacterial infection enters the bladder through the urethra. Next, the kidneys could become infected. Septicemia can sometimes result from urinary tract infection microbes entering the bloodstream. Epidemiological study indicates that urinary tract infections obtained in hospitals are typically associated with catheterization, as opposed to those acquired in the community. A major contributor to nosocomial infection, hospital-acquired urinary tract infections are less prevalent than urinary tract infections contracted in the community. In between 75 and 95 percent of cases with UTIs, Escherichia coli is the most common cause of ascending urinary tract infection. About 50% of cases of E. coli in hospitalized patients are caused by this bacteria. About 40% of urinary tract infections are caused by gram-negative bacteria such as Klebsiella, Proteus, Enterobacter, Pseudomonas, and Serratia, while the remainder of cocci are gram-positive and include E. faecalis, S. saprophyticus, and Staphylococcus aureus. The economic burden of these diseases could rise significantly due to high recurrence rates and rising antibiotic resistance in uropathogens. To control urinary tract infection new therapeutic and vaccine strategies are highly important. In light of this, the current discoveries in urogenital infections—including their etiology, epidemiology, pathogenesis, virulence factors, clinical manifestation, laboratory diagnosis, and treatment—will be covered in this chapter . Microbes of Medical Importance.